AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.31 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $607 | +239.1% | 24,531 | +214.9% | 0.01% | +250.0% |
Q1 2023 | $179 | +3.5% | 7,789 | +26.2% | 0.00% | 0.0% |
Q4 2022 | $173 | -100.0% | 6,174 | -85.5% | 0.00% | -86.7% |
Q3 2022 | $1,202,000 | +36.4% | 42,490 | +6.9% | 0.02% | +66.7% |
Q2 2022 | $881,000 | +68.1% | 39,737 | +120.6% | 0.01% | +125.0% |
Q1 2022 | $524,000 | -65.5% | 18,014 | -61.1% | 0.00% | -50.0% |
Q4 2021 | $1,521,000 | -9.9% | 46,263 | +26.4% | 0.01% | 0.0% |
Q3 2021 | $1,689,000 | +145.9% | 36,600 | +193.6% | 0.01% | +166.7% |
Q2 2021 | $687,000 | -3.2% | 12,466 | -9.3% | 0.00% | -25.0% |
Q1 2021 | $710,000 | -40.8% | 13,743 | -50.4% | 0.00% | -33.3% |
Q4 2020 | $1,199,000 | +9.9% | 27,681 | -11.2% | 0.01% | -14.3% |
Q3 2020 | $1,091,000 | +308.6% | 31,178 | +524.8% | 0.01% | +250.0% |
Q2 2020 | $267,000 | +32.8% | 4,990 | +24.1% | 0.00% | +100.0% |
Q2 2019 | $201,000 | -93.6% | 4,022 | -91.4% | 0.00% | -96.6% |
Q1 2019 | $3,151,000 | +1576.1% | 46,719 | +1043.1% | 0.03% | +1350.0% |
Q4 2018 | $188,000 | -4.1% | 4,087 | +19.1% | 0.00% | 0.0% |
Q4 2017 | $196,000 | -61.5% | 3,432 | -55.0% | 0.00% | -50.0% |
Q3 2017 | $509,000 | +20.9% | 7,625 | -6.9% | 0.00% | 0.0% |
Q2 2017 | $421,000 | -14.6% | 8,190 | -2.9% | 0.00% | 0.0% |
Q1 2017 | $493,000 | -27.9% | 8,434 | -48.5% | 0.00% | -33.3% |
Q4 2016 | $684,000 | +510.7% | 16,382 | +933.6% | 0.01% | +500.0% |
Q3 2015 | $112,000 | -80.2% | 1,585 | -73.6% | 0.00% | -66.7% |
Q1 2015 | $567,000 | -12.0% | 6,010 | +4.6% | 0.00% | 0.0% |
Q4 2014 | $644,000 | – | 5,747 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Flagship Ventures 2007 General Partner LLC | 1,930,369 | $118,428,000 | 83.56% |
Third Rock Ventures, LLC | 3,070,090 | $188,350,000 | 21.97% |
Opaleye Management Inc. | 113,500 | $6,963,225,000 | 5.43% |
BB BIOTECH AG | 1,890,521 | $115,983,000 | 4.72% |
Eventide Asset Management | 431,600 | $26,479,000 | 3.70% |
Atika Capital Management LLC | 54,000 | $3,313,000 | 2.55% |
Cormorant Asset Management, LP | 100,000 | $6,135,000 | 1.26% |
BRIDGER MANAGEMENT, LLC | 220,099 | $13,503,000 | 0.92% |
Ghost Tree Capital, LLC | 20,000 | $1,227,000 | 0.67% |
HAMILTON LANE ADVISORS LLC | 27,544 | $1,690,000 | 0.55% |